Brief: TELA Bio Reports Fourth Quarter Revenue Of $8.4 Mln
21/03/2022 20:13
March 21 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS
* SEES FY REVENUE $40 MILLION TO $45 MILLION
* Q4 REVENUE ROSE 48 PERCENT TO $8.4 MILLION
* QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $0.59
Source text for Eikon: ID:nGNX7dlcDl
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants